MARKET WRAP: Sensex gains 336 pts; Nifty above 11,750; financials advance

All that happened in the markets today

4:12 PM

Top losers on BSE500

COMPANY	PRICE(rs)	CHG(rs)	CHG(%)	VOLUME
RELIANCE POWER	7.40	-0.54	-6.80	8479629
PIRAMAL ENTERP.	2395.00	-160.25	-6.27	94640
PC JEWELLER	124.40	-7.90	-5.97	3861133
3M INDIA	23456.70	-1362.00	-5.49	683
RAJESH EXPORTS	678.00	-35.75	-5.01	54596

4:11 PM

Heatmap: S&P BSE Sensex

4:11 PM

Nifty sectoral indices at close

3:38 PM

Market at close

3:37 PM

Market at close | NSE Nifty gains 113 points, or 0.97 per cent, to close at 11,755

3:36 PM

Market at close | BSE Sensex closes 336 points higher at 39,067

3:28 PM

Nifty Auto index under pressure

3:11 PM

Sectoral trend on NSE

2:51 PM

Nifty Bank up over 400 points

2:50 PM

NEWS ALERT | Nirav Modi to remain in police custody till May 24, reports CNBC TV18

2:48 PM

NEWS ALERT | Q4 result | Piramal enterprises announces dividend of Rs 28 per share

Company declares a 22 per cent rise in profit at Rs 457 crore, revnue up 23 per cent at Rs 3,680 cr against the same quarter last year. 

2:47 PM

ICICI Securities on Maruti Suzuki India

Going forward, we expect sales and PAT to grow at a CAGR of 9.3 per cent & 8.2 per cent, respectively, in FY19-21E. We build in 5.7 per cent volume CAGR and EBITDA margin trajectory of 12.5-13 per cent over FY19-21E. We value MSIL at Rs 5,815 i.e. 20x P/E (in line with long term averages) on FY21E EPS of Rs 290.7 and assign a SELL rating on the stock. 

2:44 PM

ICICI Securities on Biocon

With better visibility, the company has optically accelerated the scalability capex and R&D, which is likely to push related expenses higher in the near term. Biosimilar launches in developed as well as emerging markets and Syngene’s performances remain key levers for the company. On an SoTP basis, we ascribe a target price of Rs 730 per share. BUY

2:36 PM

NEWS ALERT | Crude oil prices fall sharply; Brent slips over 1%

2:28 PM

Stocks that hit 52-week high on S&P BSE Sensex

COMPANY	PRICE(rs)	52 WK HIGH	CHG(rs)	CHG(%)
AUROBINDO PHARMA	824.50	833.40	28.90	3.63
BANK OF MAHA	19.39	19.55	0.73	3.91
DR REDDY'S LABS	2895.00	2954.45	-29.15	-1.00
HCL TECHNOLOGIES	1135.95	1168.00	4.80	0.42
SIEMENS	1189.45	1198.60	2.00	0.17

2:16 PM

Atul Q4 results: EBITDA at Rs 192.8 cr; Margin at 19.3%

2:15 PM

Atul Q4 results: Profit at Rs 109 cr; Revenue at Rs 1,000.8 crore

2:03 PM

MRF nears 52-week low ahead of March quarter results

MRF shares slipped 2 per cent to Rs 54,500 on Friday, falling 5 per cent in one week ahead of the January-March quarter (Q4FY19) results next week. The stock is now 1 per cent away from its 52-week low price of Rs 53,901, touched on February 19, 2019, in intra-day trade. In the past three weeks, the MRF stock has slipped 10 per cent, as compared to no changed benchmark index S&P BSE Sensex. READ MORE

2:02 PM

HDFC Life Q4 results: Net premium income up 15% at Rs 10,247 crore

2:01 PM

HDFC Life Q4 results: Net profit up 5% at Rs 364 crore

1:58 PM

NEWS ALERT | Have not defaulted on any debt obligation: Reliance Capital

1:51 PM

CG Power jumps 4% after Sunil Mittal picks up additional stake

Mittal had already bought a total of 3.3 crore shares to pick up almost 5 per cent stake in the company between March 11 and April 23 through Bharti (SBM) Holdings, one of his personal investment arms, NSE's bulk deal data showed. READ MORE

1:35 PM

Over 185 mid, small-cap stocks have given double-digit return in CY19

Shipping firm Seamec tops the list with 135 per cent gain, followed by Jammu & Kashmir Bank (61 per cent), Alankit (56 per cent) Astrazeneca Pharma India (56 per cent) and PC Jeweller (54 per cent). The rally in Seamec, a leading provider of Diving Support Vessel (DSV)-based diving services comes on the back of a strong set of numbers for the December 2018 quarter (Q3FY19). READ MORE

1:26 PM

15 stocks on RSI, Stochastic and MACD in Nifty F&O show bearish trend

There are three key technical indicators investors need to consider while taking an investment decision in stocks - the RSI (Relative Strength Index), Stochastic and MACD (moving average convergence and divergence). Although, these are all momentum indicators, they differ in their own philosophies. READ MORE

1:13 PM

Elara Capital on Cyient

Cyient

Lower growth guidance for FY20 possibly sign of deeper concerns

 

Rating: ACCUMULATE

 

Target Price : INR 660

 

Upside : 13%

 

CMP : INR 584 (as on 25 April 2019)

 

Cyient (CYL IN) reported 4QFY19 revenue which was 2.1% lower than estimates in USD terms, with services revenue in line with our estimates at USD 147.0mn and design-led-manufacturing (DLM) revenue 17.5% below estimates. DLM revenue was affected by a delay of a large order of USD 5mn. Services revenue dragged as top clients slowed in aerospace & defense (A&D) and communications verticals. Despite clocking in 10.9% YoY growth in constant currency (CC) terms in FY19 and order intake for services up by 12.6% YoY, management guided a mere high single-digit growth in the services segment in CC terms. Lower guidance may signal possible structural issues in further scaling up top clients, especially in A&D.

1:05 PM

Top gainers and losers on S&P BSE Sensex

1:05 PM

Sectoral trends on NSE at this hour

1:05 PM

Market check

1:04 PM

Market check

12:59 PM

Buzzing | Voltas at day's low